Investment Q&A

Q: Do see this as decent risk/reward for a patient investor?
Thanks

Q: Big insider purchases from Marcel Bourassa at SIS.Does 5i see this as well?

Thx

Q: Greetings 5i, may we please have an updated analysis and your opinion on AbCellera and its future prospects? What are the major positives and major risks? Thank you.

Q: Greetings 5i, it has been some time since the last question on Fulgent Genetics. The stock collapsed after its recent earnings report, your opinion on this company and its future prospects please. What are major positives (other than the cash on its balance sheet) and major risks? Thank you.

Q: Retired, dividend-income investor. Long term holder of HHL with a full position. It is my proxy for the health care sector.

Looking at your "total return" chart (capital gain + distribution) over multiple time frames, it appears to me we may be approaching some significant support in the $6,50 to $6.60 area.

Would you agree that the risk-reward ratio is swinging in favor of adding additional funds? Or, do we need to continue to sit on our hands and wait for a change in USA Healthcare Gov't leadership?

Happy to continue to just sit......Steve

Q: I am thinking of adding one of these 2 beaten down health related ETF's to my holdings. I wonder if you can tell me if you feel either or both are at risk of further decline due to Trumps RX plan, and/or their exposure to the US healthcare system which seems to be under attack by this administration?
Do you have a preference for one over the other, or do you have another name in this space that you like, and how safe do you feel the dividend is for each of them?
I am looking for a steady reliable yield and prefer ones that trade in Canada. Thank you.

Q: Why did WELL drop so much last Friday? Thank you!

Q: Hi there, can you please provide which brokerages have a negative outlook on WELL? And why they're able to continually hold this stock down... consistently?

The positives are understood, so please help explain what is actually hated about this company and its stock? Nothing the company does seems to really matters, no real institutional support, sector they are in seems hated... for longer periods, etc

Which brokerages are the most negative on WELL, are reports available? Do they have valid reasoning to stay negative on WELL?

Are they still diluting existing shareholders? Is WELL's debt the issue?

Hoping to understand as much as possible about the markets negative reasoning to push the share price consistently lower on just about all news from the company!

Looking for all negative reasoning to help convince me to finally walk away from this disaster of a stock!!!

Looks as though its a trading stock rather then a long term investment, thoughts?

Thanks!

Q: Hi Peter, Can you provide your feedback on GUD's results. And what do you think of forward prospects. It seems to be getting some traction. I still think this is a top quality management.

Thanks

Q: Hi Peter, can you comment on the latest news release today on Well Health's Wellstar company and what are the forecast earnings for this Thursday's financial reporting.

thank you

Q: My only small biotech investment (perhaps I should say Gamble) is Nervgen NVG. I am up nicely so I put it in the the "leave it alone" list of stocks that we have. Today it came to my attention that management decided to delist from the Canadian venture exchange since they have a listing on the Nasdaq (to save admin costs). I am fine with that but in the press release there was no mention of what kind of exchange rate we will receive since the Nasdaq listing is obviously in $USD. I believe that I bought our NRV in $CAD on the venture and not on the Nasdaq (our platform RBC shows that as well). So how does it work when a company delists from an exchange in one currency, leaving the remaining listing in a different currency. If you can give any additional thoughts or comments on NRV's prospects I would certainly appreciate it since it is a name that gets very little press.

Q: What is the reason for the drop. This stock was in the mid $230 back in the begining of March. Buy , sell, or hold?

Thx

Q: Updated opinion please

Q: is there enough difference between SYK and ISRG so both companies can be held ?does the cyber attack on SYK present an opportunity to buy shares? if so what entry price do you suggest? thanks Richard

Q: Please give your thoughts and expectations for Profound.
Thank you, Mike

Q: Hi team,

In attempting to increase the health sector and possibly the international percentage of my portfolio, I am considering the following stocks: ADMA,NHC, QURE,DOCS, CRVS.

Would you recommend any of these or any others for a growth portfolio at this time ?

Gratefully,

Jacques IDS

Q: Hi 5i
How were VHI earnings? Shares down big today? Do you have insight as to whats going on. Would you be sellers or holders
Thx

Q: Does the delay in VHI reporting it's quarterly results concern you at all? Would you wait until the conference call before adding to a position?

Q: Would you suggest moving out of ISRG into a different US health care company for a better long term hold? I already have ABBV. thank you

Q: RECENTLY RECOMMENDED BY GORDEN REID ON BNN. CAN I HAVE YOUR OPINION PLEASE?